New technologies are changing the way pharmaceutical supply chains operate. Here, Marc Herlant, Arthur D. Little, discusses how predictive analytics offers pharmaceutical manufacturers new supply chain capabilities.
With the cost of chronic diseases continuing to spiral and patients commonly failing to comply with medication, Chris Evans, West Pharmaceutical Services, explains why connected health could be the answer.
Chris Tozer, territory manager, UK, Ireland and Italy, Ivanti Supply Chain, looks at the complexities associated with the pharmaceutical supply chain and why legacy technology might be hindering efficiency.
Professor Carole Longson, chief scientific officer at the Association of the British Pharmaceutical Industry discusses the lack of female representation in STEM and why a woman in science is needed on the new £50 note.
Torkel Gren, Recipharm and Anders Millerhovf, CTC Clinical Trial Consultants discuss the steps needed for drug formulation during first-in-human (FIH) trials, if regulatory approval is to be achieved.
For all the effort and investment drugs companies have put into improving business agility, the gap between vision and reality is glaring. This could be because companies have yet to transform R&D decision-making, says James Man, Kinapse.
Ben Jones, technical manager, global serialisation services at PCI Pharma Services, discusses the complex world of serialisation and what strategies pharma companies can implement.
Lab automation has come a long way since the days of industrial robots, with new advancements increasing efficiency between systems and workers. Peter Harris, HighRes Biosolutions, discusses how far the sector has moved and what the future holds.
